3 results
The primary objective of Do CHANGE is to develop a health ecosystem for integrated disease management of citizens with high bloodpressure and patients with ischemic heart disease or heart failure. The system will give them access to a set of…
The primary objective of this study is to compare PFS with LY2875358 plus erlotinib therapy with erlotinibmonotherapy as first-line treatment in metastatic NSCLC patients with activating EGFR mutations who havedisease control after an 8-week lead-in…
Main objective of this study is to characterize the possible benefits of the new Phonak Marvel CI-CROS device on speech understanding in noise, including its implemented beamformers (UltraZoom and StereoZoom) using different noise setups.